Back to Search
JON KROOK, MD
MD
Surgery Physician
NPI: 1902841588IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgical Critical Care Physician
Surgery — Surgical Critical Care
Code: 2086S0102X
44455(MN)
Surgery PhysicianPrimary
Surgery
Code: 208600000X
44455(MN)
CMS Specialties
PrimaryGENERAL SURGERY
Additional
CRITICAL CARE (INTENSIVISTS)
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 1997
Research & Publications (20)
Joint investigation of working conditions, environmental and system performance at recycling centres--development of instruments and their usage.
PMID 19660737·Appl Ergon·2010
8-other
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.
PMID 19546817·J Thorac Oncol·2009
8-other
Swedish recovered wood waste: linking regulation and contamination.
PMID 17509861·Waste Manag·2008
8-other
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
PMID 17687151·J Clin Oncol·2007
4-observational
Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate.
PMID 17010430·Leuk Res·2007
5-case
Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.
PMID 17553200·Clin Colorectal Cancer·2007
3-trial
Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
PMID 17409917·J Thorac Oncol·2006
8-other
Sources of heavy metal contamination in Swedish wood waste used for combustion.
PMID 16198553·Waste Manag·2006
8-other
Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
PMID 17409859·J Thorac Oncol·2006
3-trial
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
PMID 16538529·Breast Cancer Res Treat·2006
2-rct
A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
PMID 16847887·Cancer·2006
4-observational
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
PMID 16945169·Clin Colorectal Cancer·2006
2-rct
Phase II trial of dolastatin-10 in patients with advanced breast cancer.
PMID 15868383·Invest New Drugs·2005
3-trial
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
PMID 15912493·Cancer·2005
3-trial
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
PMID 15852407·Cancer·2005
3-trial
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
PMID 15452187·J Clin Oncol·2005
3-trial
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.
PMID 15677624·Ann Oncol·2005
3-trial
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
PMID 15803016·Am J Clin Oncol·2005
3-trial
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.
PMID 16381626·Clin Breast Cancer·2005
3-trial
Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial.
PMID 15278681·Support Care Cancer·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 6405 FRANCE AVE S, SUITE W440
EDINA, MN 55435 - Phone
- (952) 927-7004
Quick Facts
- NPI
- 1902841588
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile